GSK3B and hepatocellular carcinoma: sCD146 secreted by CD146-positive tumors mediates important pro-angiogenic and pro-tumoral effects [40], while sCLU promotes chemoresistance, metastasis and CSC phenotype in HCC by activating the AKT/GSK3β/β-catenin axis [41].